Interrelationship among muscle, fat, and bone: Connecting the dots on cellular, hormonal, and whole body levels

Ageing Research Reviews

Volumn 15, Issue 1, 2014, Pages 51-60

  Ilich, Jasminka Z ^a   Kelly, Owen J ^b   Inglis, Julia E ^a   Panton, Lynn B ^a   Duque, Gustavo ^c   Ormsbee, Michael J ^a  

^a FLORIDA STATE UNIVERSITY   (United States)

^b ABBOTT LABORATORIES   (United States)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Inflammation; Mesenchymal stem cells; Osteopenic obesity; Osteosarcopenic obesity; Sarcopenia

Indexed keywords

ADIPONECTIN; ESTROGEN; FAT; INTERLEUKIN 15; INTERLEUKIN 6; IRISIN; LEPTIN; LEPTIN RECEPTOR; OSTEOCALCIN; UNCLASSIFIED DRUG; UNCOUPLING PROTEIN 1; HORMONE;

ADIPOSE TISSUE; BONE; BONE STRENGTH; BONE TISSUE; COMPUTER ASSISTED TOMOGRAPHY; DUAL ENERGY X RAY ABSORPTIOMETRY; HAND GRIP; HUMAN; MESENCHYMAL STEM CELL; MUSCLE; MUSCLE MASS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; OSTEOPOROSIS; OSTEOSARCOPENIC OBESITY; REVIEW; SARCOPENIA; ADIPOCYTE; AGED; ENDOCRINE SYSTEM; METABOLISM; PHYSIOLOGY; STEM CELL;

ADIPOCYTES; ADIPOSE TISSUE; AGED; BONE AND BONES; ENDOCRINE SYSTEM; HORMONES; HUMANS; MUSCLES; STEM CELLS;

EID: 84897835443     PISSN: 15681637     EISSN: 18729649     Source Type: Journal    
DOI: 10.1016/j.arr.2014.02.007     Document Type: Review

References (125)

1. Ackert-Bicknell C., Rosen C. The genetics of PPARG and the skeleton. PPAR Res. 2006, 2006 October 11; Pubmed PMID: 17347532. PubMed Central PMCID: PMC1679963. 10.1155/PPAR/2006/93258.
2. Aleshin S., Grabeklis S., Hanck T., Sergeeva M., Reiser G. Peroxisome proliferator-activated receptor (PPAR)-{gamma} positively controls and PPAR{alpha} negatively controls cyclooxygenase-2 expression in rat brain astrocytes through a convergence on PPAR{beta}/{delta} via mutual control of PPAR expression levels. Mol. Pharmacol. 2009, 76:414-424.
3. Araujo-Jorge T.C., Waghabi M.C., Bailly S., Feige J.J. The TGF-beta pathway as an emerging target for Chagas disease therapy. Clin. Pharmacol. Ther. 2012, 92:613-621.
4. Argiles J.M., Lopez-Soriano J., Almendro V., Busquets S., Lopez-Soriano F.J. Cross-talk between skeletal muscle and adipose tissue: a link with obesity?. Med. Res. Rev. 2005, 25:49-65.
5. Baumgartner R.N., Koehler K.M., Gallagher D., Romero, Heymsfield L., Ross S., Garry R., Lindeman P. Epidemiology of sarcopenia among the elderly in New Mexico. Am. J. Epidemiol. 1998, 147:755-763.
6. Belanger C., Luu- The V., Dupont P., Tchernof A. Adipose tissue intracrinology: potential importance of local androgen/estrogen metabolism in the regulation of adiposity. Horm. Metab. Res. 2002, 34:737-745.
7. Bentzinger C.F., Wang Y.X., Rudnicki M.A. Building muscle: molecular regulation of myogenesis. Cold Spring Harb. Perspect. Biol. 2012, 2012 February 1; Pubmed PMID: 22300977. 10.1101/cshperspect.a008342.
8. Beyer I., Mets T., Bautmans I. Chronic low-grade inflammation and age-related sarcopenia. Curr. Opin. Clin. Nutr. Metab. Care 2012, 15:12-22.
9. Binkley N., Krueger D., Buehring B. What's in a name revisited: should osteoporosis and sarcopenia be considered components of dysmobility syndrome?. Osteoporos. Int. 2013, Pubmed PMID: 23903951. 10.1007/s00198-013-2427-1.
10. Bonewald L.F., Kiel D.P., Clemens T.L., Esser K., Orwoll E., O'Keefe R., Fielding R. Forum on bone and skeletal muscle interactions: summary of the proceedings of an ASBMR Workshop. J. Bone Miner. Res. 2013, 28:1857-1865.
11. Bostrom P., Wu J., Jedrychowski M., Korde A., Ye L., Lo J., Rasbach K., Boström E., Choi J., Long J., Kajimura S., Zingaretti M., Vind B., Tu H., Cinti S., Højlund K., Gygi S., Spiegelman B. A PGC1-alpha-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature 2012, 481:463-468.
12. Bradford P.G., Gerace K.V., Roland R.L., Chrzan B.G. Estrogen regulation of apoptosis in osteoblasts. Physiol. Behav. 2010, 99:181-185.
13. Buday B., Pach F.P., Literati-Nagy B., Vitai M., Vecsei Z., Koranyi L. Serum osteocalcin is associated with improved metabolic state via adiponectin in females versus testosterone in males. Gender specific nature of the bone-energy homeostasis axis. Bone 2013, 57(1):98-104. Epub 2013 July 22. 10.1016/j.bone.2013.07.018.
14. Cao J.J. Effects of obesity on bone metabolism. J. Orthop. Surg. Res. 2011, 201:1. Pubmed PMID: 21676245. PMCID PMC: 3141563. 10.1186/1749-799X-6-30.
15. Cao Y. Angiogenesis modulates adipogenesis and obesity. J. Clin. Invest. 2007, 117:2362-2368.
16. Cawthorn W., Sethi J. TNF-alpha and adipocyte biology. FEBS Lett. 2008, 582:117-131.
17. Chen S.E., Jin B., Li Y.P. TNF-alpha regulates myogenesis and muscle regeneration by activating p38 MAPK. Am. J. Physiol. Cell Physiol. 2007, 292:C1660-C1671.
18. Chien M.Y., Huang T.Y., Wu Y.T. Prevalence of sarcopenia estimated using a bioelectrical impedance analysis prediction equation in community-dwelling elderly people in Taiwan. J. Am. Geriatr. Soc. 2008, 56:1710-1715.
19. Clark B.C., Manini T.M. Sarcopenia =/= dynapenia. J. Gerontol. A: Biol. Sci. Med. Sci. 2008, 63:829-834.
20. Clarke D.C., Liu X. Decoding the quantitative nature of TGF-beta/Smad signaling. Trends Cell Biol. 2008, 18:430-442.
21. Cock T.A., Auwerx J. Leptin: cutting the fat off the bone. Lancet 2003, 362:1572-1574.
22. Compston J. Obesity and bone. Curr. Osteoporos. Rep. 2013, 11:30-35.
23. Cooke P., Naaz A. Role of estrogens in adipocyte development and function. Exp. Biol. Med. (Maywood) 2004, 229:1127-1135.
24. Cruz-Jentoft A.J., Baeyens J.P., Bauer J.M.J., Boirie Y., Cederholm T., Landi F., Martin F., Michel J., Rolland Y., Schneider S., Topinková E., Vandewoude M., Zamboni M. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing 2010, 39:412-423.
25. Dargent-Molina P., Schott A.M., Hans D., Favier F., Grandjean H., Baudoin C., Meunier P., Bréart G. Separate and combined value of bone mass and gait speed measurements in screening for hip fracture risk: results from the EPIDOS study. Epidemiologie de l'Osteoporose. Osteoporos. Int. 1999, 9:188-192.
26. De Laet C., Kanis J.A., Odén A., Johanson H., Johnell O., Delmas P., Eisman J., Kroger H., Fujiwara S., Garnero P., McCloskey E., Mellstrom D., Melton L., Meunier P., Pols H., Reeve J., Silman A., Tenenhouse A., Kanis J. Body mass index as a predictor of fracture risk: a meta-analysis. Osteoporos. Int. 2005, 16:1330-1338.
27. Domiciano D., Figueiredo C., Lopes J., Caparbo V., Takayama L., Menezes P., Bonfak E., Pereirak R. Discriminating sarcopenia in community-dwelling older women with high frequency of overweight/obesity: the Sao Paulo Ageing & Health Study (SPAH). Osteoporos. Int. 2012, 24:595-603.
28. Dufour A.B., Hannan M.T., Murabito J.M., Kielk D.P., McLean R.R. Sarcopenia definitions considering body size and fat mass are associated with mobility limitations: the Framingham Study. J. Gerontol. A: Biol. Sci. Med. Sci. 2013, 68:168-174.
29. Duque G., Li W., Vidal C., Bermeo S., Rivas D., Henderson J. Pharmacological inhibition of PPARγ increases osteoblastogenesis and bone mass in male C57BL/6 mice. J. Bone Miner. Res. 2013, 28:639-648.
30. Elefteriou F., Ahn J.D., Takeda S., Starbuck M., Yang X., Liu X., Kondo H., Richards W., Bannon T., Noda M., Clement K., Vaisse C., Karsenty G. Leptin regulation of bone resorption by the sympathetic nervous system and CART. Nature 2005, 434:514-520.
31. Enns D.L., Tiidus P.M. The influence of estrogen on skeletal muscle: sex matters. Sports Med. 2010, 40:41-58.
32. Ensrud K.E., Ewing S.K., Stone K.L., Cauley J.A., Bowman P.J., Cummings S.R. Intentional and unintentional weight loss increase bone loss and hip fracture risk in older women. J. Am. Geriatr. Soc. 2003, 51:1740-1747.
33. Faggioni R., Feingold K.R., Grunfeld C. Leptin regulation of the immune response and the immunodeficiency of malnutrition. FASEB J. 2001, 15:2565-2571.
34. Fain J.N. Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the nonfat cells. Vitam. Horm. 2006, 74:443-477.
35. FNIH Progress through partnerships: Consensus building processes to address major unmet medical needs. Sarcopenia Consensus Summit, 2012. Available at (accessed November 2013). http://www.biomarkersconsortium.org/pdf/Sarcopenia%20PDF/3.%20FNIH%20Introductory%20Slides%20for%20the%20Sarcopenia%20Meeting%20final%204-18-2012%20Maria%20Vassileva.pdf.
36. Foletta V.C., White L.J., Larsen A.E., Léger B., Russell A.P. The role and regulation of MAFbx/atrogin-1 and MuRF1 in skeletal muscle atrophy. Pflugers Arch. 2011, 461:325-335.
37. Forbes A.P. Fuller Albright. His concept of postmenopausal osteoporosis and what came of it. Clin. Orthop. Relat. Res. 1991, 269:128-141.
38. Gimble J.M., Zvonic S., Floyd Z.E., Kassem M., Nuttall M.E. Playing with bone and fat. J. Cell. Biochem. 2006, 98:251-266.
39. Gonnelli S., Caffarelli C., Del Santo K., Cadirni A., Guerriero C., Lucani B., Franci B., Nuti R. The relationship of ghrelin and adiponectin with bone mineral density and bone turnover markers in elderly men. Calcif. Tissue Int. 2008, 83:55-60.
40. Heber D., Ingles S., Ashley J.M., Maxwell M.H., Lyons R.F., Elashoff R.M. Clinical detection of sarcopenic obesity by bioelectrical impedance analysis. Am. J. Clin. Nutr. 1996, 64:472S-477S.
41. Hikiji H., Takato T., Shimizu T., Ishii S. The roles of prostanoids, leukotrienes, and platelet-activating factor in bone metabolism and disease. Prog. Lipid Res. 2008, 47:107-126.
42. Hotamisligil G.S. Inflammation and metabolic disorders. Nature 2006, 444:860-867.
43. Hu E., Tontonoz P., Spiegelman B.M. Transdifferentiation of myoblasts by the adipogenic transcription factors PPAR gamma and C/EBP alpha. Proc. Natl. Acad. Sci. U.S.A. 1995, 92:9856-9860.
44. Hubbard R., O'Mahony M., Calver B., Woodhouse K. Nutrition, inflammation, and leptin levels in aging and frailty. JAGS 2008, 56:279-284.
45. Ilich-Ernst J., Brownbill R.A., Ludemann M.A., Fu R. Critical factors for bone health in women across the age span: how important is muscle mass?. Medscape Womens Health 2002, 7:2. PMID: 12142855. Available at: http://www.medscape.com/viewarticle/432910.
46. Inglis J.E., Panton L.B., Ormsbee M.J., Kelly O.J., Ilich J.Z. Defining osteosarcopenic obesity and identifying its prevalence in women across the age span. J. Bone Miner. Res. 2013, Available at: http://www.asbmr.org/ItineraryBuilder/PresentationDetail.aspx?pid=1632d275-b3cc-4c49-978f-ef80e4b33153&ptag=AuthorDetail&aid.
47. Isenmann S., Cakouros D., Zannettino A., Shi S., Gronthos S. hTERT transcription is repressed by Cbfa1 in human mesenchymal stem cell populations. J. Bone Miner. Res. 2007, 22:897-906.
48. Jeong J.H., Jung Y.K., Kim H.J., Jin J.S., Kim H.N., Kang S.M., Kim S.Y., van Wijnen A.J., Stein J.L., Lian J.B., Stein G.S., Kato S., Choi J.Y. The gene for aromatase, a rate-limiting enzyme for local estrogen biosynthesis, is a downstream target gene of Runx2 in skeletal tissues. Mol. Cell. Biol. 2010, 30:2365-2375.
49. Jurimae J., Rembel K., Jurimae T., Rehand M. Adiponectin is associated with bone mineral density in perimenopausal women. Horm. Metab. Res. 2005, 37:297-302.
50. Kaaks R. Nutrition, insulin, IGF-1 metabolism and cancer risk: a summary of epidemiological evidence. Novartis Found. Symp. 2004, 262:247-260.
51. Kameda T., Mano H., Yuasa T., Mori Y., Miyazawa K., Shiokawa M., Nakamaru Y., Hiroi E., Hiura K., Kameda A., Yang N., Hakeda Y., Kumegawa M. Estrogen inhibits bone resorption by directly inducing apoptosis of the bone-resorbing osteoclasts. J. Exp. Med. 1997, 186:489-495.
52. Kanazawa I., Yamaguchi T., Yamamoto M., Yamauchi M., Yano S., Sugimoto T. Relationships between serum adiponectin levels versus bone mineral density, bone metabolic markers, and vertebral fractures in type 2 diabetes mellitus. Eur. J. Endocrinol. 2009, 160:265-273.
53. Kanis J.A. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study Group. Osteoporos. Int. 1994, 4:368-381.
54. Karsenty G., Ferron M. The contribution of bone to whole-organism physiology. Nature 2012, 481:314-320.
55. Kelly O.J., Gilman J.C., Kim Y., Ilich J.Z. Long chain polyunsaturated fatty acids may mutually benefit both obesity and osteoporosis. Nutr. Res. 2013, 33:521-533.
56. Kelly T.L., Wilson K.E., Heymsfield S.B. Dual energy X-ray absorptiometry body composition reference values from NHANES. PLoS One 2009, 4:e7038. PMC2737140. 10.1371/journal.pone.0007038.
57. Kim Y., Kelly O.J., Ilich J.Z. α-Linolenic acid, conjugated linoleic acid and calcium as found in dairy products, modulate bone and fat cell metabolism. Lipids 2013, 48:787-802.
58. Koroglu B.K., Kiris F., Ersoy I.H., Sutcu R., Yildiz M., Aksu O., Ermis F., Ersoy S., Tamer M.N. Relation of leptin, adiponectin and insulin resistance to bone mineral density in type 2 diabetic postmenopausal women. Endocrynol. Pol. 2011, 62:429-435.
59. Kovner I., Taicher G.Z., Mitchell A.D. Calibration and validation of EchoMRI whole body composition analysis based on chemical analysis of piglets, in comparison with the same for DXA. Int. J. Body Compos. Res. 2010, 8:17-29. PMCID: PMC2998350.
60. Landin-Wilhelmsen K., Wilhelmsen L., Bengtsson B.A. Postmenopausal osteoporosis is more related to hormonal aberrations than to lifestyle factors. Clin. Endocrinol. 1999, 51:387-394.
61. Langen R.C., Van Der Velden J.L., Schols A.M., Kelders M.C., Wouters E.F., Janssen-Heininger Y.M. Tumor necrosis factor-alpha inhibits myogenic differentiation through MyoD protein destabilization. FASEB J. 2004, 18:227-237.
62. Lang T.F. The bone-muscle relationship in men and women. J. Osteoporos. 2011, 30(2011):2011. PubMed PMID: 702735. 10.4061/2011/702735.
63. Lauretani F., Russo C.R., Bandinelli S., Bartali B., Cavazzini C., Di Iorio A., Corsi A.M., Rantanen T., Guralnik J.M., Ferrucci L. Age-associated changes in skeletal muscles and their effect on mobility: an operational diagnosis of sarcopenia. J. Appl. Physiol. 2003, 95:1851-1860.
64. Lecka-Czernik B., Suva L.J. Resolving the two "bony" faces of PPAR-gamma. PPAR Res. 2006, 2006 September 20; Pubmed PMID: 17259664. PMCID: PM1679961. 10.1155/PPAR/2006/27489.
65. Lecke S.B., Morsch D.M., Spritzer P.M. Leptin and adiponectin in the female life course. Braz. J. Med. Biol. Res. 2011, 44:381-387.
66. Lee B., Shao J. Adiponectin and lipid metabolism in skeletal muscle. Acta Pharm. Sin. B 2012, 2:335-434.
67. Lee N.K., Karsenty G. Reciprocal regulation of bone and energy metabolism. Trends Endocrinol. Metab. 2008, 19:161-166.
68. Lee N.K., Sowa H., Hinoi E., Ferron M., Ahn J.D., Confavreux C., Dacquin R., Mee P.J., McKee M.D., Jung D.Y., Zhang Z., Kim J.K., Mauvais-Jarvis F., Ducy P., Karsenty G. Endocrine regulation of energy metabolism by the skeleton. Cell 2007, 130:456-469.
69. Lenchik L., Register T.C., Hsu F.C., Lohman K., Nicklas B.J., Freedman B.I., Langefeld C.D., Carr J.J., Bowden D.W. Adiponectin as a novel determinant of bone mineral density and visceral fat. Bone 2003, 33:646-651.
70. Lewiecki E.M., Watts N.B., McClung M.R., Petak S.M., Bachrach L.K., Shepherd J.A., Downs R.W. International Society for Clinical Densitometry. Official position of the International Society for Clinical Densitometry. J. Clin. Endocrinol. Metab. 2004, 89:3651-3655.
71. Liu J.M., Zhao H.Y., Zhao L., Chen Y., Zhang L.Z., Tao B., Sun L.H., Zhao Y.J., Wang W.Q., Xu M.Y., Chen J.L., Ning G. An independent positive relationship between the serum total osteocalcin level and fat-free mass in healthy premenopausal women. J. Clin. Endocrinol. Metab. 2013, 98(5):2146-2152. 2013 May; Epub 2013 April. 10.1210/jc.2013-1112.
72. Liu Y., Chen F., Odle J., Lin X., Zhu H., Shi H., Hou Y., Yin J. Fish oil increases muscle protein mass and modulates Akt/FOXO, TLR4, and NOD signaling in weaning piglets after LPS challenge. J. Nutr. 2013, July 1, 2013 jn.113.176255.
73. Luo S.W., Zhang C., Zhang B., Kim C.H., Qiu Y.Z., Du Q.S., Mei L., Xiong W.C. Regulation of heterochromatin remodelling and myogenin expression during muscle differentiation by FAK interaction with MBD2. EMBO J. 2009, 28:2568-2582.
74. Luo X.H., Guo L.J., Xie H., Yuan L.Q., Wu X.P., Zhou H.D., Liao E.Y. Adiponectin stimulates RANKL and inhibits OPG expression in human osteoblasts through the MAPK signaling pathway. J. Bone Miner. Res. 2006, 21:1648-1656.
75. Mackey D.C., Eby J.G., Harris F., Taaffe D.R., Cauley J.A., Tylavsky F.A., Harris T.B., Lang T.F., Cummings S.R., Health, Aging, and Body Composition Study Group Prediction of clinical non-spine fractures in older black and white men and women with volumetric BMD of the spine and areal BMD of the hip: the Health, Aging, and Body Composition Study. J. Bone Miner. Res. 2007, 22:1862-1868.
76. Matkovic V., Jelic T., Wardlaw G.M., Ilich J.Z., Goel P.K., Wright J.K., Andon M.B., Smith K.T., Heaney R.P. Timing of peak bone mass in Caucasian females and its implication for the prevention of osteoporosis. Inference from a cross-sectional model. J. Clin. Invest. 1994, 93:799-808.
77. Matthews G.D., Huang C.L., Sun L., Zaidi M. Translational musculoskeletal science: is sarcopenia the next clinical target after osteoporosis?. Ann. N.Y. Acad. Sci. 2011, 1237:95-105.
78. McCarthy T.L., Chang W.Z., Liu Y., Centrella M. Runx2 integrates estrogen activity in osteoblasts. J. Biol. Chem. 2003, 278:43121-43129.
79. Metzger D., Imai T., Jiang M., Takukawa R., Desvergne B., Wahli W., Chambon P. Functional role of RXRs and PPARgamma in mature adipocytes. Prostaglandins Leukot. Essent. Fatty Acids 2005, 73:51-58.
80. Motyl K.J., Rosen C.J. Understanding leptin-dependent regulation of skeletal homeostasis. Biochimie 2012, 94:2089-2096.
81. Mukai T., Otsuka F., Otani H., Yamashita M., Takasugi K., Inagaki K., Yamamura M., Makino H. TNF-alpha inhibits BMP-induced osteoblast differentiation through activating SAPK/JNK signaling. Biochem. Biophys. Res. Commun. 2007, 356:1004-1010.
82. Napolitano A., Miller S.R., Murgatroyd P.R., Coward W.A., Wright A., Finer N., De Bruin T.W., Bullmore E.T., Nunez D.J. Validation of a quantitative magnetic resonance method for measuring human body composition. Obesity (Silver Spring) 2008, 16:191-198. 10.1038/oby.2007.29.
83. Newman A.B., Kupelian V., Visser M., Simonsick E., Goodpaster B., Nevitt M., Kritchevsky S.B., Tylavsky F.A., Rubin S.M., Harris T.B. Health ABC Study Investigators Sarcopenia: alternative definitions and associations with lower extremity function. J. Am. Geriatr. Soc. 2003, 51:1602-1609.
84. Ng F., Boucher S., Koh S., Sastry K.S., Chase L., Lakshmipathy U., Choong C., Yang Z., Vemuri M.C., Rao M.S., Tanavde V. PDGF, TGF-beta, and FGF signaling is important for differentiation and growth of mesenchymal stem cells (MSCs): transcriptional profiling can identify markers and signaling pathways important in differentiation of MSCs into adipogenic, chondrogenic, and osteogenic lineages. Blood 2008, 112:295-307.
85. Nishikawa K., Nakashima T., Takeda S., Isogai M., Hamada M., Kimura A., Kodama T., Yamaguchi A., Owen M.J., Takahashi S., Takayanagi H. Maf promotes osteoblast differentiation in mice by mediating the age-related switch in mesenchymal cell differentiation. J. Clin. Invest. 2010, 120:3455-3465.
86. Orsatti F.L., Nahas E.A., Nahas-Neto J., Orsatti C.L., Marocolo M., Barbosa-Neto O., da Mota G.R. Low appendicular muscle mass is correlated with femoral neck bone mineral density loss in postmenopausal women. BMC Musculoskelet. Disord. 2011, 2011 October 7; Pubmed PMID: 21981859. PubMed Central PMCID: PMC322531012. 10.1186/1471-2474-12-225.
87. Oshima K., Nampei A., Matsuda M., Iwaki M., Fukuhara A., Hashimoto J., Yoshikawa H., Shimomura I. Adiponectin increases bone mass by suppressing osteoclast and activating osteoblast. Biochem. Biophys. Res. Commun. 2005, 331:520-526.
88. Ozkurt B., Ozkurt Z.N., Altay M., Aktekin C.N., Caglayan O., Tabak Y. The relationship between serum adiponectin level and anthropometry, bone mass, osteoporotic fracture risk in postmenopausal women. Eklem Hastalik Cerrahisi 2009, 20:78-84.
89. Pedersen B.K. Muscles and their myokines. J. Exp. Biol. 2011, 214(Pt 1, Pt 2):337-346.
90. Prado C.M., Wells J.C., Smith S.R., Stephan B.C., Siervo M. Sarcopenic obesity: a critical appraisal of the current evidence. Clin. Nutr. 2012, 31:583-601.
91. Pratesi A., Tarantini F., Di Bari M. Skeletal muscle: an endocrine organ. Clin. Cases Miner. Bone Metab. 2013, 10:11-14.
92. Raschke S., Eckel J. Adipo-myokines: two sides of the same coin-mediators of inflammation and mediators of exercise. Mediators Inflamm. 2013, 2013:320724. Epub 2013 June 3. 10.1155/2013/320724.
93. Rasouli N., Kern P.A. Adipocytokines and the metabolic complications of obesity. J. Clin. Endocrinol. Metab. 2008, 93:64S-73S.
94. Reid I.R. Relationships between fat and bone. Osteoporos. Int. 2008, 19:595-606.
95. Richards J.B., Valdes A.M., Burling K., Perks U.C., Spector T.D. Serum adiponectin and bone mineral density in women. J. Clin. Endocrinol. Metab. 2007, 92:1517-1523.
96. Robinson L.J., Borysenko C.W., Blair H.C. Tumor necrosis factor family receptors regulating bone turnover: new observations in osteoblastic and osteoclastic cell lines. Ann. N.Y. Acad. Sci. 2007, 1116:432-443.
97. Rosen C.J., Bouxsein M.L. Mechanisms of disease: is osteoporosis the obesity of bone?. Nat. Clin. Pract. Rheumatol. 2006, 2:35-43.
98. Rosenberg I.H. Summary comments. Am. J. Clin. Nutr. 1989, 50:1231-1233.
99. Roubenoff R. Origins and clinical relevance of sarcopenia. Can. J. Appl. Physiol. 2001, 26:78-89.
100. Sáinz N., Rodríguez A., Catalán V., Becerril S., Ramírez B., Gómez-Ambrosi J., Frühbeck G. Leptin administration favors muscle mass accretion by decreasing FoxO3a and increasing PGC-1alpha in ob/ob mice. PLoS One 2009, 4(9):e6808. 2009 September 4. 10.1371/journal.pone.0006808.
101. Sandhu M.S., Gibson J.M., Heald A.H., Dunger D.B., Wareham N.J. Association between insulin-like growth factor-I: insulin-like growth factor-binding protein-1 ratio and metabolic and anthropometric factors in men and women. Cancer Epidemiol. Biomarkers Prev. 2004, 13:166-170.
102. Scheele C., Nielsen S., Kelly M., Broholm C., Nielsen A.R., Taudorf S., Pedersen M., Fischer C.P., Pedersen B.K. Satellite cells derived from obese humans with type 2 diabetes and differentiated into myocytes in vitro exhibit abnormal response to IL-6. PLos One 2012, 2012 June 26; Pubmed PMID: 22761857. PMCID PMC3383673. 10.1371/journal.pone.0039657.
103. Serrano A.L., Baeza-Raja B., Perdiguero E., Jardí M., Muñoz-Cánoves P. Interleukin-6 is an essential regulator of satellite cell-mediated skeletal muscle hypertrophy. Cell Metab. 2008, 7:33-44.
104. Sheu Y., Marshall L.M., Holton K.F., Caserotti P., Boudreau R.M., Strotmeyer E.S., Cawthon P.M., Cauley J.A. Abdominal body composition measured by quantitative computed tomography and risk of non-spine fractures: the Osteoporotic Fractures in Men (MrOS) Study. Osteoporos. Int. 2013, 24:2231-2241. 10.1007/s00198-013-2322-9.
105. Shin H., Liu P.-Y., Panton L.B., Ilich J.Z. Physical performance in relation to body composition and bone mineral density in healthy, overweight and obese postmenopausal women. J. Ger. Phys. Therapy 2014, 37(1):7-16. 10.1519/JPT.0b013e31828af203.
106. Shin H., Panton L.B., Dutton G.R., Ilich J.Z. Relationship of physical performance with body composition and bone mineral density in individuals over 60 years of age: a systematic review. J. Aging Res. 2011, 2011 January 23; Pubmed PMID:191896. 10.4061/2011/191896.
107. Singh J., Verma N.K., Kansagra S.M., Kate B.N., Dey C.S. Altered PPAR gamma expression inhibits myogenic differentiation in C2C12 skeletal muscle cells. Mol. Cell. Biochem. 2007, 294:163-171.
108. Solinas G., Summermatter S., Mainieri D., Gubler M., Pirola L., Wymann M.P., Rusconi S., Montani J.P., Seydoux J., Dulloo A.G. The direct effect of leptin on skeletal muscle thermogenesis is mediated by substrate cycling between de novo lipogenesis and lipid oxidation. FEBS Lett. 2004, 577:539-544.
109. Stables M.J., Gilroy D.W. Old and new generation lipid mediators in acute inflammation and resolution. Prog. Lipid Res. 2011, 50:35-51.
110. Takazawa T., Yamauchi T., Tsuchida A., Takata M., Hada Y., Iwabu M., Okada-Iwabu M., Ueki K., Kadowaki T. Peroxisome proliferator-activated receptor {gamma} agonist rosiglitazone increases the expression of very low density lipoprotein receptor gene in adipocytes. J. Biol. Chem. 2009, 284:30049-30057.
111. Tenta R., Kontogianni M.D., Yiannakouris N. Association between circulating levels of adiponectin and indices of bone mass and bone metabolism in middle-aged post-menopausal women. J. Endocrinol. Invest. 2012, 35:306-311.
112. Wang J., Liu R., Hawkins M., Barzilai N., Rossetti L. A nutrient-sensing pathway regulates leptin gene expression in muscle and fat. Nature 1998, 393:684-688.
113. Washington T.A., White J.P., Davis J.M., Wilson L.B., Lowe L.L., Sato S., Carson J.A. Skeletal muscle mass recovery from atrophy in IL-6 knockout mice. Acta Physiol. (Oxf.) 2011, 202:657-669.
114. Weisberg S.P., McCann D., Desai M., Rosenbaum M., Leibel R.L., Ferrante A.W. Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 2003, 112:1796-1808.
115. Weitzmann M.N., Pacifici R. Estrogen deficiency and bone loss: an inflammatory tale. J. Clin. Invest. 2006, 116:1186-1194.
116. Williams G.A., Wang Y., Callon K.E., Watson M., Lin J.M., Lam J.B., Costa J.L., Orpe A., Broom N., Naot D., Reid I.R., Cornish J. In vitro and in vivo effects of adiponectin on bone. Endocrinology 2009, 150:3603-3610.
117. Wu J., Boström P., Sparks L.M., Ye L., Choi J.H., Giang A.H., Khandekar M., Virtanen K.A., Nuutila P., Schaart G., Huang K., Tu H., Van Marken Lichtenbelt W.D., Hoeks J., Enerbäck S., Schrauwen P., Spiegelman B.M. Beige adipocytes are a distinct type of thermogenic fat cell in mouse and human. Cell 2012, 150:366-376.
118. Wucher H., Ciangura C., Poitou C., Czernichow S. Effects of weight loss on bone status after bariatric surgery: association between adipokines and bone markers. Obes. Surg. 2008, 18:58-65.
119. Yoon M.J., Lee G.Y., Chung J.J., Ahn Y.H., Hong S.H., Kim J.B. Adiponectin increases fatty acid oxidation in skeletal muscle cells by sequential activation of AMP-activated protein kinase, p38 mitogen-activated protein kinase, and peroxisome proliferator-activated receptor alpha. Diabetes 2006, 55:2562-2570.
120. Yu S., Reddy J.K. Transcription coactivators for peroxisome proliferator-activated receptors. Biochim. Biophys. Acta (BBA) Mol. Cell. Biol. Lipids 2007, 1771:936-951.
121. Zahorska-Markiewicz B., Janowska J., Olszanecka-Glinianowicz M., Zurakowski A. Serum concentrations of TNF-alpha and soluble TNF-alpha receptors in obesity. Int. J. Obes. Relat. Metab. Disord. 2000, 24:1392-1395.
122. Zaidi S.K., Pande S., Pratap J., Gaur T., Grigoriu S., Ali S.A., Stein J.L., Lian J.B., van Wijnen A.J., Stein G.S. Runx2 deficiency and defective subnuclear targeting bypass senescence to promote immortalization and tumorigenic potential. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:19861-19866.
123. Zamboni M., Mazzali G., Fantin F., Rossi A., Di Francesco V. Sarcopenic obesity: a new category of obesity in the elderly. Nutr. Metab. Cardiovasc. Dis. 2008, 18:388-395.
124. Zhao L.J., Jiang H., Papasian C.J., Maulik D., Drees B., Hamilton J., Deng H.W. Correlation of obesity and osteoporosis: effect of fat mass on the determination of osteoporosis. J. Bone Miner. Res. 2008, 23:17-29.
125. Zhao L.J., Liu Y.J., Liu P.Y., Hamilton J., Recker R.R., Deng H.W. Relationship of obesity with osteoporosis. J. Clin. Endocrinol. Metab. 2007, 92:1640-1646.